DPP4 and congenital bilateral aplasia of vas deferens from CFTR mutation: The application of DPP-4 inhibitor decreased the expression of inflammatory cytokines IL-2, TNFα, IL-1β, and IL-6 to suppress the progression of CAVD (Choi et al., 2021).